A small number of people who received Johnson & Johnson’s COVID-19 vaccine have developed blood clots, the European Medicines Agency said Friday.
The agency’s committee in charge of assessing medicines has launched a review of the vaccine’s safety that will delve into the reports of post-vaccination blood clots.
